For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230608:nRSH0042Ca&default-theme=true
RNS Number : 0042C STS Global Income & Growth Trust 08 June 2023
To: RNS
From: STS Global Income & Growth
Trust plc
LEI: 549300UZ1Y7PPQYJGE19
Date: 8 June 2023
STS Global Income & Growth Trust plc (the "Company")
Appointment of new Director
The Board is pleased to announce the appointment of Gillian Elcock as a
Non-Executive Director of the Company with effect from 21 September 2023.
Gillian is the founder of Denny Ellison, an independent investment research
and training company, and was its Managing Director for ten years. Prior to
this, she worked as an equity research analyst for several years at Putnam
Investments and Insight Investment. She was named a finalist in the
'Investment Analyst of the Year' category of the Women in Investment Awards
2018. She started her career as a management consultant at The Boston
Consulting Group.
Gillian is a Non-Executive Director of International Biotechnology Trust plc.
She is also a member of the Board of the CFA UK and was previously Chair of
its Networks Steering Committee and a member of its Nominating Committee.
Gillian holds an MBA from the Harvard Business School and MEng and BSc degrees
from the Massachusetts Institute of Technology.
There are no other details or disclosures required under LR 9.6.13R of the
Financial Conduct Authority Listing Rules.
John Evans, Chairman, commented "I am delighted that Gillian is joining our
Board. She has a wealth of investment experience and will bring a
valuable perspective to Board discussions. My colleagues and I very much look
forward to working with her."
Juniper Partners Limited
Company Secretary
Enquiries: 0131 378 0500
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAGZGGVVNMGFZM